Inventor
ASCULAI SAMUEL SIMON
CA24 patents
⚠️ This page may combine multiple inventors who share the name “ASCULAI SAMUEL SIMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HYAL PHARMA CORP
22 patentsUS5824658AOct 20, 1998
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP70 citations96
US5639738AJun 17, 1997
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
HYAL PHARMA CORP56 citations96
US6022866AFeb 8, 2000
Use of hyaluronic acid and forms to prevent arterial restenosis
HYAL PHARMA CORP81 citations95
US6218373B1Apr 17, 2001
Formulations containing hyaluronic acid
HYAL PHARMA CORP39 citations92
US6140312AOct 31, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP24 citations92
US6136793AOct 24, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP20 citations92
US6103704AAug 15, 2000
Therapeutic methods using hyaluronic acid
HYAL PHARMA CORP25 citations92
US6017900AJan 25, 2000
Topical composition containing hyaluronic acid and nsaids
HYAL PHARMA CORP28 citations92
US5977088ANov 2, 1999
Formulations containing hyaluronic acid
HYAL PHARMA CORP51 citations92
US5962433AOct 5, 1999
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP22 citations92
US5942498AAug 24, 1999
Formulations containing hyaluronic acid
HYAL PHARMA CORP21 citations92
US5914322AJun 22, 1999
Treatment of disease and conditions
HYAL PHARMA CORP44 citations92
US5910489AJun 8, 1999
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP40 citations92
US5834444ANov 10, 1998
Hyaluronic acid and salts thereof inhibit arterial restenosis
HYAL PHARMA CORP22 citations92
US5792753AAug 11, 1998
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
HYAL PHARMA CORP44 citations92
US5674857AOct 7, 1997
Use of hyaluronic acid to repair ischemia reperfusion damage
HYAL PHARMA CORP25 citations92
US6114314ASep 5, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP31 citations91
US5972906AOct 26, 1999
Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
HYAL PHARMA CORP35 citations89
US5847002ADec 8, 1998
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
HYAL PHARMA CORP25 citations89
US5990096ANov 23, 1999
Formulations containing hyaluronic acid
HYAL PHARMA CORP17 citations83
US5817642AOct 6, 1998
Clearing of atherosclerosis
HYAL PHARMA CORP15 citations74
US5767106AJun 16, 1998
Treatment of disease and conditions associated with macrophage infiltration
HYAL PHARMA CORP13 citations72